Stock LAB B GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.
Add to a list
To use this feature you must be a member
Log inSign up

Company Genomma Lab Internacional, S.A.B. de C.V.

Equities

LAB B

MX01LA010006

Pharmaceuticals

End-of-day quote Mexican S.E.
Other stock markets
 06:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
14.08 MXN 0.00% Intraday chart for Genomma Lab Internacional, S.A.B. de C.V. -8.93% -0.56%
Feb. 22 Transcript : Genomma Lab Internacional, S.A.B. de C.V., Q4 2023 Earnings Call, Feb 22, 2024
Feb. 21 Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Business Summary

Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.

Number of employees: 1,783

Sales per Business

MXN in Million2021Weight2022Weight Delta
Pharmaceutical Products and Personal Care Products
100.0 %
15,487 100.0 % 16,820 100.0 % +8.61%

Sales per region

MXN in Million2021Weight2022Weight Delta
International
59.9 %
9,024 58.3 % 10,069 59.9 % +11.59%
Mexico
40.1 %
6,464 41.7 % 6,751 40.1 % +4.44%

Managers

Managers TitleAgeSince
Marco Sparvieri CEO
 Chief Executive Officer - -
Rodrigo Alonso Herrera Aspra FOU
 Founder - 96-10-29
Antonio Zamora Galland DFI
 Director of Finance/CFO - -
Jorge Luis Brake Valderrama BRD
 Director/Board Member - 18-09-09
Marco Francisco Forastieri Muñoz BRD
 Director/Board Member - 12-03-28
Alejandro Bastón Patiño IRO
 Public Communications Contact - 08-09-30

Members of the board

Members of the board TitleAgeSince
Burkhard Wittek BRD
 Director/Board Member 70 18-04-17
Juan Carlos Gavito Aspe BRD
 Director/Board Member - -
Rodrigo Alonso Herrera Aspra FOU
 Founder - 96-10-29
Sabrina Lucila Herrera Aspra BRD
 Director/Board Member - 97-12-31
Jorge Ricardo Gutiérrez Muñoz BRD
 Director/Board Member 80 -
Marco Francisco Forastieri Muñoz BRD
 Director/Board Member - 12-03-28
Jorge Luis Brake Valderrama BRD
 Director/Board Member - 18-09-09
Carlos Javier Vara Alonso BRD
 Director/Board Member - 18-04-17
Javier Vale Castilla BRD
 Director/Board Member - -
Ignacio Gonzalez Rodriguez BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,020,000,000 712,097,600 ( 69.81 %) 71,951,660 ( 7.054 %) 69.81 %

Shareholders

NameEquities%Valuation
MFS International (UK) Ltd.
2.533 %
25,839,330 2.533 % 25 M $
Skagen AS (Investment Management)
2.176 %
22,200,000 2.176 % 21 M $
Lemanik Asset Management SA
1.555 %
15,863,042 1.555 % 15 M $
BlackRock México Operadora SA de CV SOFI
1.500 %
15,304,159 1.500 % 15 M $
Operadora de Fondos Banorte SA de CV
1.174 %
11,973,292 1.174 % 11 M $
Denker Capital (Pty) Ltd.
0.8247 %
8,412,284 0.8247 % 8 M $
Swedbank Robur Fonder AB
0.6114 %
6,236,714 0.6114 % 6 M $
Old Mutual Investment Group (Pty) Ltd.
0.4000 %
4,079,696 0.4000 % 4 M $
North of South Capital LLP
0.3977 %
4,056,696 0.3977 % 4 M $
Westwood International Advisors, Inc.
0.2807 %
2,863,361 0.2807 % 3 M $

Company contact information

Genomma Lab Internacional SAB de CV

Avendia Antonio Dovalí Jaime, 70 Torre C, Piso 2, Despacho A

01210, Mexico City

+

http://www.genommalab.com
address Genomma Lab Internacional, S.A.B. de C.V.(LAB B)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Genomma Lab Internacional, S.A.B. de C.V.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
14.08 MXN
Average target price
21.03 MXN
Spread / Average Target
+49.35%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V. Stock Genomma Lab Internacional, S.A.B. de C.V.
-0.56% 771M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+27.97% 676B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+23.58% 554B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.02% 349B
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.85% 318B
ABBVIE INC. Stock AbbVie Inc.
+6.25% 291B
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.96% 210B
NOVARTIS AG Stock Novartis AG
-0.41% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-10.02% 194B
PFIZER, INC. Stock Pfizer, Inc.
-11.81% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. LAB B Stock
  4. Company Genomma Lab Internacional, S.A.B. de C.V.